Literature DB >> 22101901

Using three legacy measures to develop a health-related quality of life tool for young adult survivors of childhood cancer.

I-Chan Huang1, Gwendolyn P Quinn, Pey-Shan Wen, Elizabeth A Shenkman, Dennis A Revicki, Kevin Krull, Zhushan Li, Patricia D Shearer.   

Abstract

BACKGROUND: Little attention has been paid to selecting and developing health-related quality of life (HRQOL) measurement tools for young adult survivors of childhood cancer (YASCC). The primary purpose of this study was to develop a HRQOL tool for YASCC based on three legacy instruments.
METHODS: Data collected from 151 YASCC were analyzed. HRQOL was measured using the Medical Outcomes Study SF-36, Quality of Life in Adult Cancer Survivors, and Quality of Life-Cancer Survivor. We used the following stages to develop our HRQOL tool: mapping items from three instruments into a common HRQOL construct, checking dimensionality using confirmatory factor analyses (CFA), and equating items using Rasch modeling.
RESULTS: We assigned 123 items to a HRQOL construct comprised of six generic and eight survivor-specific domains. CFA retained 107 items that meet the assumptions of unidimensionality and local independence. Rasch analysis retained 68 items that satisfied the indices of information-weighted/outlier-sensitive fit statistic mean square. However, items in most domains possess relatively easy measurement properties, whereas YASCC's underlying HRQOL was on the middle to higher levels.
CONCLUSIONS: Psychometric properties of the established tool for measuring HRQOL of YASCC were not satisfied. Future studies need to refine this tool, especially adding more challenging items.

Entities:  

Mesh:

Year:  2011        PMID: 22101901      PMCID: PMC3328688          DOI: 10.1007/s11136-011-0055-9

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  48 in total

Review 1.  Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation.

Authors:  Geoffrey R Norman; Jeff A Sloan; Kathleen W Wyrwich
Journal:  Med Care       Date:  2003-05       Impact factor: 2.983

2.  Fertility issues for young adult survivors of childhood cancer.

Authors:  Brad J Zebrack; Jacqueline Casillas; Lindsay Nohr; Heidi Adams; Lonnie K Zeltzer
Journal:  Psychooncology       Date:  2004-10       Impact factor: 3.894

3.  Psychological functioning of adolescent and young adult survivors of pediatric malignancy.

Authors:  T D Elkin; S Phipps; R K Mulhern; D Fairclough
Journal:  Med Pediatr Oncol       Date:  1997-12

4.  Late effects of therapy in survivors of Ewing's sarcoma family tumors.

Authors:  B Novakovic; T R Fears; M E Horowitz; M A Tucker; L H Wexler
Journal:  J Pediatr Hematol Oncol       Date:  1997 May-Jun       Impact factor: 1.289

5.  Comparison of psychologic outcome in adult survivors of childhood acute lymphoblastic leukemia versus sibling controls: a cooperative Children's Cancer Group and National Institutes of Health study.

Authors:  L K Zeltzer; E Chen; R Weiss; M D Guo; L L Robison; A T Meadows; J L Mills; H S Nicholson; J Byrne
Journal:  J Clin Oncol       Date:  1997-02       Impact factor: 44.544

6.  Long-term survival and quality of life in patients treated with a national all protocol 15-20 years earlier: IDM/HDM and late effects?

Authors:  P J Moe; A Holen; A Glomstein; B Madsen; M Hellebostad; T Stokland; K W Wefring; J Steen-Johnsen; B Nielsen; H Howlid; S Børsting; C Hapnes
Journal:  Pediatr Hematol Oncol       Date:  1997 Nov-Dec       Impact factor: 1.969

7.  Health-related quality of life of adults surviving malignancies in childhood.

Authors:  M Apajasalo; H Sintonen; M A Siimes; L Hovi; C Holmberg; H Boyd; A Mäkelä; J Rautonen
Journal:  Eur J Cancer       Date:  1996-07       Impact factor: 9.162

8.  Measurement of the quality of life in cancer survivors.

Authors:  B R Ferrell; K H Dow; M Grant
Journal:  Qual Life Res       Date:  1995-12       Impact factor: 4.147

9.  Quality of life and psychosocial adjustment of young patients after treatment of bone cancer.

Authors:  R Felder-Puig; A K Formann; A Mildner; W Bretschneider; B Bucher; R Windhager; A Zoubek; S Puig; R Topf
Journal:  Cancer       Date:  1998-07-01       Impact factor: 6.860

Review 10.  CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment.

Authors:  Andy Trotti; A Dimitrios Colevas; Ann Setser; Valerie Rusch; David Jaques; Volker Budach; Corey Langer; Barbara Murphy; Richard Cumberlin; C Norman Coleman; Philip Rubin
Journal:  Semin Radiat Oncol       Date:  2003-07       Impact factor: 5.934

View more
  5 in total

1.  Missing content from health-related quality of life instruments: interviews with young adult survivors of childhood cancer.

Authors:  Gwendolyn P Quinn; I-Chan Huang; Devin Murphy; Katie Zidonik-Eddelton; Kevin R Krull
Journal:  Qual Life Res       Date:  2013-02       Impact factor: 4.147

2.  Patterns of unmet needs in adolescent and young adult (AYA) cancer survivors: in their own words.

Authors:  Alex W K Wong; Ting-Ting Chang; Katrina Christopher; Stephen C L Lau; Lynda K Beaupin; Brad Love; Kim L Lipsey; Michael Feuerstein
Journal:  J Cancer Surviv       Date:  2017-03-29       Impact factor: 4.442

Review 3.  Application of Rasch Analysis for Development and Psychometric Properties of Adolescents' Quality of Life Instruments: A Systematic Review.

Authors:  Sahar Dabaghi; Fatemeh Esmaielzadeh; Camelia Rohani
Journal:  Adolesc Health Med Ther       Date:  2020-11-11

4.  The Childhood Cancer Survivor Study-Neurocognitive Questionnaire (CCSS-NCQ) revised: item response analysis and concurrent validity.

Authors:  Kelly M Kenzik; I-Chan Huang; Tara M Brinkman; Brandon Baughman; Kirsten K Ness; Elizabeth A Shenkman; Melissa M Hudson; Leslie L Robison; Kevin R Krull
Journal:  Neuropsychology       Date:  2014-06-16       Impact factor: 3.295

5.  Emotional distress impacts quality of life evaluation: a report from the Childhood Cancer Survivor Study.

Authors:  I-Chan Huang; Tara M Brinkman; Gregory T Armstrong; Wendy Leisenring; Leslie L Robison; Kevin R Krull
Journal:  J Cancer Surviv       Date:  2017-01-09       Impact factor: 4.442

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.